Leo Cancer Care is based in London, United Kingdom. It has raised $150M in total funding. Latest round: Series D.
Leo Cancer Care is based in London, United Kingdom. Leo Cancer Care has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in July 2024. The round record for Leo Cancer Care runs through 2024; nothing later has been disclosed. Investors on record include PR Yu, Eventide Asset Management, Wisconsin Alumni Research Foundation (WARF), Alumni Ventures, Bioshore, Pureland Venture Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
Round data for Leo Cancer Care is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in London and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026